Trametinib + DABRAFENIB for glioma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Feb 2026: Trial registered, NCT07440290
  2. 1 Apr 2026: Trial started, NCT07440290

The trials

NCT07440290: DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

State
Under way
Phase
Phase 2 and Phase 3
People
30 planned
Started
1 Apr 2026
Primary completion
Oct 2029
Arms
Treatment Arm 07: Dabrafenib and Trametinib
Results
None posted
  1. 27 Feb 2026: Trial registered
  2. 1 Apr 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.